Edwards Lifesciences (NY:EW)

86.87 +1.72 (+2.02%)

Delayed Quote Updated: 11:26 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

April 24, 2025

Via Benzinga

Thursday's pre-market session: top gainers and losers in the S&P500 index ↗

April 24, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat ↗

April 23, 2025

Edwards Lifesciences stock was flat late Wednesday after the medtech company beat profit views and delivered in-line sales.

Via Investor's Business Daily

Topics ETFs

Edwards Lifesciences Reports First Quarter Results

April 23, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

A Look Into Edwards Lifesciences Inc's Price Over Earnings ↗

February 26, 2025

Via Benzinga

Peering Into Edwards Lifesciences's Recent Short Interest ↗

February 18, 2025

Via Benzinga

Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday? ↗

April 23, 2025

Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.

Via Benzinga

Topics Government

A Look at Edwards Lifesciences's Upcoming Earnings Report ↗

April 22, 2025

Via Benzinga

Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue

April 18, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Is Edwards Lifesciences Gaining or Losing Market Support? ↗

April 17, 2025

Via Benzinga

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

April 16, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

April 14, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

April 11, 2025

Via Benzinga

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry ↗

April 04, 2025

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...

Via Benzinga

Topics Government World Trade

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

March 31, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock ↗

March 28, 2025

Via Benzinga

How Is The Market Feeling About Edwards Lifesciences? ↗

March 17, 2025

Via Benzinga

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

February 25, 2025

From Edwards Lifesciences Corporation

Via Business Wire

Top S&P500 movers in Wednesday's session ↗

February 12, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength ↗

February 12, 2025

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company projects continued expansion in 2025.

Via Benzinga

These S&P500 stocks are moving in today's session ↗

February 12, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday? ↗

February 12, 2025

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...

Via Benzinga

Topics Economy

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

February 12, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Edwards Beats Fourth-Quarter Forecasts, But Shares Slip ↗

February 11, 2025

Edwards Lifesciences stock fell slightly late Tuesday after the company kept its outlook for 2025 despite beating forecasts.

Via Investor's Business Daily

Edwards Lifesciences Reports Fourth Quarter Results

February 11, 2025

From Edwards Lifesciences Corporation

Via Business Wire

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? ↗

February 11, 2025

U.S.

Via Benzinga

Earnings Scheduled For February 11, 2025 ↗

February 11, 2025

Via Benzinga

Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 10, 2025

Medical technology company Edwards Lifesciences (NYSE:EW) will be reporting results tomorrow after market close. Here’s what to look for.

Via StockStory

EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW

February 07, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.